Active
    SME

    Q-Line Biotech Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Q-Line Biotech Ltd IPO opened on 21 May 2026 and closed on 25 May 2026, with a price band of ₹326–₹343 per share. The IPO had a lot size of 400 shares, requiring a minimum investment of ₹2,74,400 per lot at the upper price band. The issue size was ₹214.48 crore, and the shares get listed on 29 May 2026.

    Q-Line Biotech Ltd IPO Details

    Listing Date

    29 May 2026

    Bid Price

    ₹326 - ₹343

    Lot Size

    400 Shares

    Minimum Investment

    ₹2,74,400 / 2 Lots

    Issue Size

    ₹214.48 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    21st May

    tick

    Offer End Date

    25th May

    tick

    Allotment Date

    26th May

    tick

    Refund Initiation

    27th May

    tick

    Demat Transfer

    27th May

    tick

    Listing Date

    29th May

    About Q-Line Biotech Ltd IPO

    Founded in 2010, Q-Line Biotech Ltd. operates in the in-vitro diagnostics (IVD) segment with activities spanning the development, manufacturing, marketing, import, and distribution of diagnostic reagents, consumables, and healthcare diagnostic equipment. The company supplies diagnostic products to hospitals, diagnostic laboratories, and medical colleges, either directly or through its distribution network. Its product portfolio includes clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and point-of-care (POC) devices along with rapid testing solutions. Over the years, the company has expanded its presence in the diagnostics sector through manufacturing operations, research and development activities, and quality control processes. According to company information, Q-Line Biotech Ltd. has been supplying diagnostic equipment and IVD products since 2013 to address varied healthcare diagnostic requirements across multiple institutions.

    The company’s manufacturing operations include the production of reagents and diagnostic kits, along with the supply and manufacturing of pathology and IVD equipment. As of December 31, 2025, the company reported an annual manufacturing capacity of around 1.4 million kits across categories such as haematology, clinical chemistry, and rapid/ELISA testing, in addition to approximately 1,200 Selectra Machines. As of March 31, 2026, the manufacturing division included 126 employees and 223 third-party workers involved across research and development, supply chain functions, and production-related activities. The company states that its operations are supported by collaborations with external partners and internal teams to maintain manufacturing and operational processes within the diagnostic healthcare segment.

    Q-Line Biotech Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 92.24% 67.51%
    Public Group 7.76% 32.49%

    Q-Line Biotech Ltd IPO Reservation

    QIB Shares Offered 11,88,000 (19%)
    NII (HNI) Shares Offered 8,91,600 (14.26%)
    Retail Shares Offered 20,79,200 (33.25%)
    Anchor Investor Shares Offered 17,81,200 (28.48%)
    Total Shares Offered 62,53,200
    Total Shares With Anchor Investor 62,53,200

    Q-Line Biotech Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 2 800 ₹2,74,400
    Retail (Max) 2 800 ₹2,74,400
    S HNI (Min) 3 1,200 ₹4,11,600
    S HNI (Max) 7 2,800 ₹9,60,400
    B HNI (MIN) 8 3,200 ₹10,97,600

    Q-Line Biotech Ltd IPO Anchor Portion Size

    Bid Date May 20, 2026
    Shares Offered 17,81,200
    Anchor Investment Details 61

    Q-Line Biotech Ltd IPO registrar

    Purva Sharegistry (I) Pvt Ltd
    Phone Number 91 22 2301 2517 / 8261
    Email Id newissue@purvashare.com
    Website www.purvashare.com

    Q-Line Biotech Ltd IPO Lead Manager

    1. Hem Securities Limited

    2. Share India Capital Services Private Limited

    Q-Line Biotech Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹246.19 Cr ₹189.95 Cr ₹161.81 Cr
    Reserves and Surplus ₹229.92 Cr ₹188.38 Cr ₹160.24 Cr
    Total Borrowing ₹225.48 Cr ₹164.95 Cr ₹96.91 Cr

    Q-Line Biotech Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 11,88,000 14,72,37,200 123.937
    Non Institutional Investors (NIIs) 12,04,800 13,04,66,800 108.2892
    Retail Individual Investors (RIIs) 20,79,200 14,85,41,600 71.4417
    Total 44,72,000 42,62,45,600 95.3143

    Strength of Q-Line Biotech Ltd

    • Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control.
    • Diversified product portfolio with focus on IVD industry.
    • Widespread distribution network with a presence across all four regions.
    • Long standing relationships with customers.
    • Track record of healthy financial performance.
    • Experienced Promoter and Management team.

    Risks Involved

    • Any disruption, stoppage, slowdown or shutdown in the company manufacturing facilities or process or research and development activities could adversely affect its business, financial condition, cash flows and results of operations.
    • Any delay, interruption or reduction in the supply of the company raw materials, trade goods from its suppliers and manufacturers both domestic and imported, or an increase in the costs of such raw materials, trade goods may adversely impact the pricing and supply of the company products and has an adverse effect on the company business, financial condition, cash flows and results of operations.
    • The company business is dependent on the sale of its products through distributors which also include the company group entity POCT services. The loss of any of these distributors or third parties for any reason may adversely affect the marketing and distribution of its products and could negatively impact the company business, results of operations, financial conditions and cash flows.
    • The company is dependent on certain key suppliers to procure a significant portion of the company Raw material for production of reagents and for traded machines. Any denial of supplies or loss of the relationship with them could result in disruption in its operations, which could has an adverse effect on the company business, financial condition, results of operations and cash flows.
    • The company is required to obtain, maintain or renew its statutory and regulatory approvals, licenses, and registrations to operates the company business.
    • For manufacturing of its machines and reagents, the company is dependent on the agreement with the European companies, any failures to renew the agreement or entering into the agreement on the terms which is not favourable for its may impact the company business operations, financial condition and cash flows.
    • The company erstwhile associate company i.e. POCT Science House Private Limited and its promoters namely Saurabh Garg and Amita Garg has been subject to search and seizure operations by the Income-tax Department and any adverse outcome of these proceedings may adversely affect the company financial condition.
    • The company operations is concentrated in North India, and any loss of business in such region could has an adverse effect on the company business, results of operations and financial condition.
    • The Company requires a significant amount of working capital for continuing growth. Its inability to meet the company working capital requirements may adversely affect its results of operations.
    • The company is subject to risks arising from exchange rate fluctuations.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Q-Line Biotech IPO

    • India’s in-vitro diagnostics (IVD) industry is undergoing changes influenced by evolving healthcare requirements and wider access to diagnostic services.

    • Diagnostic testing continues to play an important role in identifying medical conditions and supporting treatment decisions.

    • The COVID-19 pandemic contributed to a rise in demand for IVD products, although market growth moderated as infection levels declined.

    • Despite the stabilisation in demand after the pandemic, the sector continues to witness growth due to ongoing healthcare developments.

    • Population growth and increasing life expectancy in India are contributing to higher demand for diagnostic and screening solutions.

    • Improved access to healthcare facilities across urban and semi-urban regions is supporting the expansion of the diagnostics market.

    • The increasing prevalence of chronic illnesses, including diabetes, cardiovascular conditions, and cancer, is driving the need for regular diagnostic testing.

    • Preventive healthcare awareness is increasing, leading to greater adoption of early screening and monitoring practices.

    • Changing public attitudes towards early disease detection and timely diagnosis are influencing the long-term development of the IVD industry.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Q-Line Biotech IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹28,29,00,000
    M K Sons Fine Jewels Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹153.0 - 162.0
    IPO Size
    ₹2,75,39,99,872
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    Issue Prize
    344.00
    Listing Day Close
    378.20(9.88%)
    Issue Prize
    586.00
    Listing Day Close
    576.35(-1.71%)
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    179.00
    Listing Day Close
    170.05(-5.03%)
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    700.00
    Listing Day Close
    1133.65(62.00%)
    Issue Prize
    151.00
    Listing Day Close
    138.30(-8.61%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)

    Frequently Asked Questions

    What is Q-Line Biotech Ltd IPO?

    Q-Line Biotech Ltd IPO is a SME IPO of 62,53,200 equity shares of a face value of ₹10 aggregating up to ₹214.48 Crores. The issue is priced at ₹326 to ₹343 per share. The minimum order quantity is 400 Shares. The IPO opens on May 21, 2026, and closes on May 25, 2026. Purva Sharegistry (I) Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

    When Q-Line Biotech Ltd IPO will open?

    The Q-Line Biotech Ltd IPO opens on May 21, 2026 and closes on May 25, 2026.

    What is the lot size of Q-Line Biotech Ltd?

    Q-Line Biotech Ltd lot size is 400 shares, and the minimum amount required is ₹2,74,400.

    How to apply for Q-Line Biotech Ltd IPO?

    You can apply in Q-Line Biotech Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Q-Line Biotech Ltd IPO allotment?

    The finalization of Basis of Allotment for Q-Line Biotech Ltd IPO will be done on May 26, 2026, and the allotted shares will be credited to your demat account by May 27, 2026.

    When is Q-Line Biotech Ltd IPO listing date?

    The Q-Line Biotech Ltd listing date is May 29, 2026.

    Who is the registrar of Q-Line Biotech Ltd IPO?

    The registrar of Q-Line Biotech Ltd IPO is Purva Sharegistry (I) Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    Hem Securities Limited,Share India Capital Services Private Limited will be the book-running lead manager of this IPO.

    What is the fresh issue of Q-Line Biotech Ltd IPO?

    The fresh issue size is ₹214.48 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Q-Line Biotech Ltd?

    Retail investors can subscribe to a minimum of one lot, 400 shares and ₹2,74,400 amount.

    How can I approve the UPI mandate request for Q-Line Biotech Ltd IPO?

    To apply for Q-Line Biotech Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Q-Line Biotech Ltd?

    The price of each Q-Line Biotech Ltd share will be ranging in between ₹326 to ₹343 per share.

    What is the cut-off time for the UPI mandate for Q-Line Biotech Ltd IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, May 25, 2026.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |